Goodrx Holdings Inc Capital Reinvestment Ratio

Latest as of September 2025: 0.24x

Goodrx Holdings Inc capital reinvestment ratio. Goodrx Holdings Inc (GDRX) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow ($76.02 Million) in capital expenditures ($18.00 Million). Check total reinvestment intensity of Goodrx Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

$76.02 Million
USD

Capital Expenditures

$18.00 Million
USD

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Goodrx Holdings Inc (2018–2024)

Capital reinvestment ratio of Goodrx Holdings Inc from 2018 to 2024. This chart tracks Goodrx Holdings Inc's Capital Reinvestment Ratio across 7 annual periods. Also explore net asset momentum of Goodrx Holdings Inc to track the company's year-over-year net asset growth rate.

Goodrx Holdings Inc Capital Reinvestment Ratio by Year (2018–2024)

Goodrx Holdings Inc capital reinvestment ratio by year from 2018 to 2024. For the full cash flow conversion analysis, see GDRX cash generation efficiency.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.38x $183.89 Million $70.35 Million ▼ -5.1%
2023 0.40x $138.29 Million $55.77 Million ▲ +7.2%
2022 0.38x $146.78 Million $55.21 Million ▲ +95.2%
2021 0.19x $178.78 Million $34.46 Million ▼ -29.3%
2020 0.27x $131.34 Million $35.82 Million ▲ +295.1%
2019 0.07x $83.29 Million $5.75 Million ▼ -9.7%
2018 0.08x $45.25 Million $3.46 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow